Insiders Harrow, Inc.

Equities

Market Closed - OTC Markets Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
20.89 ^USD	-0.52%		-0.52%	+86.52%

06-24	Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index	CI
06-21	Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained	MT

Harrow Names Greg Dipasquale as Senior Vice President, Head of Commercial	05-13	CI
Harrow, Inc. Announces Board of Director Appointments	01-29	CI
Harrow, Inc. Appoints John P. Saharek as President and Chief Executive Officer of its ImprimisRx Division	01-03	CI
Harrow, Inc. Announces Board and Committee Changes	11-03	CI
Insider Buy: Harrow Health	15/08/23	MT
Harrow Health, Inc. Announces Appointment of Mark Mannebach as Head of Regulatory Affairs and Pharmacovigilance	06/03/23	CI
Insider Buy: Harrow Health	23/12/22	MT
Insider Buy: Harrow Health	23/12/22	MT
Insider Sell: Harrow Health	04/10/22	MT
Akari Therapeutics Names Melissa Bradford-Klug COO	13/06/22	MT
Harrow Health, Inc. Announces Management Changes	31/03/22	CI
Harrow Health, Inc Announces Board Changes	23/08/21	CI
Insider Trends: Insider Purchase of Harrow Health Stock Continues 90-Day Positive Trend	20/08/21	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	22/07/21	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	22/06/21	MT
Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Harrow Health	21/05/21	MT
Insider Trends: Harrow Health Insider 90-Day Buying Trend Prolonged with Purchase	22/12/20	MT
Harrow Health Appoints Larry Van Horn to its Board of Directors	30/09/20	CI
Harrow Health, Inc. Announces Board and Committee Changes	17/03/20	CI
Harrow Health, Inc. Announces Launch of Mayfield Pharmaceuticals; to Appoint Melissa Bradford-Klug to Lead Mayfield Pharmaceuticals, Inc	31/07/19	CI

No results for this search